Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadian Influence on Renal Clearance of Aminoglycosides in Cystic Fibrosis Patients
2008-005110-41Phase 4Active
- Sponsor
- not applicable
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tobramycin in cystic fibrosis (CF) (2 arms), sponsored by not applicable. Primary endpoint: Renal elimination constant (Kelm) of tobramycin. Started Dec 2008; status: active.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2008-005110-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005110-41.